3,313 results on '"Neubauer, Stefan"'
Search Results
152. Kiosk 11R-TC-08 - Ninerafaxstat Modulates Cardiac Energy Metabolism in Cardio-metabolic Syndromes: A Mechanistic, Hyperpolarized MR Trial
153. Kiosk 11R-FB-09 - Multimodal Stress Testing Unmasks Latent Energetic Deficit in Subjects with Subtly Depressed Ejection FBaction
154. CMR 4-137 - Past Breast Cancer Is Linked to Increased Cardiovascular Risk and Adverse Remodelling of the Heart
155. CMR 4-136 - Investigating the Role of the Right Ventricle in Hfpef Using Exercise CMR
156. CMR 3-87 - Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
157. LegoNet: Alternating Model Blocks for Medical Image Segmentation
158. Characterizing the hypertensive cardiovascular phenotype in the UK Biobank
159. 178 Cardiac manifestations of igg4-related disease
160. Estimating Uncertainty in Neural Networks for Cardiac MRI Segmentation: A Benchmark Study
161. 3 Differential effects of bariatric surgery type on cardiac reverse remodelling
162. Sex-based differences in risk factors for incident myocardial infarction and stroke in the UK Biobank
163. Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)
164. Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
165. Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
166. Response by Peterzan et al to Letter Regarding Article, “Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction”
167. Abstract 16702: Myocardial Deformation Analysis in Hypertrophic Cardiomyopathy With Sarcomere Mutations: Insights From 2,221 Patients Within the NHLBI-HCM Registry
168. Abstract 16467: A Novel CT-derived Radiotranscriptomic Signature of Perivascular Adipose Tissue Stratifies COVID-19 Vascular Cytokine Burst and Predicts in Hospital Outcomes
169. Abstract 13594: Adverse Right Ventricular Remodelling, Function and Stress Responses in Obesity: Implications for Severe Acute Respiratory Illness
170. Towards the Semantic Enrichment of Free-Text Annotation of Image Quality Assessment for UK Biobank Cardiac Cine MRI Scans
171. Sex-based differences in risk factors for incident myocardial infarction and stroke in the UK Biobank
172. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions
173. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure
174. Independent Left Ventricular Morphometric Atlases Show Consistent Relationships with Cardiovascular Risk Factors: A UK Biobank Study
175. Image‐Based Biological Heart Age Estimation Reveals Differential Aging Patterns Across Cardiac Chambers.
176. Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.
177. Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review.
178. Cardiovascular Magnetic Resonance
179. Contributors
180. Cardiac Magnetic Resonance Spectroscopy
181. End-Diastolic and End-Systolic LV Morphology in the Presence of Cardiovascular Risk Factors: A UK Biobank Study
182. 3D Cardiac Shape Prediction with Deep Neural Networks: Simultaneous Use of Images and Patient Metadata
183. High Throughput Computation of Reference Ranges of Biventricular Cardiac Function on the UK Biobank Population Cohort
184. Image Quality Assessment for Population Cardiac Magnetic Resonance Imaging
185. Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction
186. Myocardial Energetics in Obesity: Enhanced ATP Delivery Through Creatine Kinase With Blunted Stress Response
187. Noninvasive In Vivo Assessment of Cardiac Metabolism in the Healthy and Diabetic Human Heart Using Hyperpolarized 13C MRI
188. Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification
189. Characterizing the hypertensive cardiovascular phenotype in the UK Biobank
190. Validation of Cardiovascular Magnetic Resonance–Derived Equation for Predicted Left Ventricular Mass Using the UK Biobank Imaging Cohort: Tool for Donor-Recipient Size Matching
191. Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated With Cardiac Morphogenesis and Heart Failure Development
192. Fully-automated left ventricular mass and volume MRI analysis in the UK Biobank population cohort: evaluation of initial results
193. State-of-the-art review: stress T1 mapping—technical considerations, pitfalls and emerging clinical applications
194. Ganzheitliche und auf maschinellen Lernverfahren basierende Qualitätsüberwachung
195. ABNORMAL SKELETAL METABOLISM BUT NOT CARDIAC DYSFUNCTION AS A CAUSE FOR FATIGUE POST COVID-19
196. Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy
197. The role of obesity-related cardiovascular remodelling in mediating incident cardiovascular outcomes: a population-based observational study
198. 29 Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype
199. 10 Impaired stress myocardial oxygenation precedes contractile abnormalities in three models of cardiac hypertrophy: insights from a novel oxygen sensitive cardiac magnetic resonance approach
200. 30 A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.